Tema Oncology ETF

Tema Oncology ETF is offered by Tema, a leading player in the field of passive investments.

The total expense ratio of Tema Oncology ETF is 0.75%, which means that investors pay 75 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, Tema Oncology ETF does not comply with the EU UCITS investor protection directives.

The P/E ratio of Tema Oncology ETF is 19.8.

The current average trading volume of Tema Oncology ETF is 43,853.98.

Tema Oncology ETF is domiciled in US.

The fund was launched on 8/15/2023.

The Tema Oncology ETF mainly invests in Healthcare companies.

The NAV of Tema Oncology ETF amounts to 36.46 M USD.

The price-to-book ratio is 7.186.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.